Allianz Asset Management
IDYA icon

Allianz Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Allianz Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,400
Closed -$393K – 2267
2024
Q3 		$393K Buy
12,400
+2,600
+27% +$98.6K ﹤0.01% 1914
2024
Q2 		$344K Sell
9,800
-5,100
-34% -$202K ﹤0.01% 1935
2024
Q1 		$654K Sell
14,900
-4,900
-25% -$211K ﹤0.01% 1534
2023
Q4 		$704K Hold
19,800
– – ﹤0.01% 1737
2023
Q3 		$534K Sell
19,800
-5,700
-22% -$145K ﹤0.01% 1898
2023
Q2 		$599K Buy
+25,500
New +$524K ﹤0.01% 1688

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Allianz Asset Management's IDYA Position: Q4 2024 in Review

Allianz Asset Management sold out of IDEAYA Biosciences (IDYA) in Q4 2024, closing a stake of 12,400 shares — an estimated $393K sold.

Allianz Asset Management first reported a position in IDYA in Q2 2023 and held it in 6 quarters. The position peaked at $704K in Q4 2023. 206 funds tracked by Wall St. Rank hold IDYA as of Q4 2024.

  • Allianz Asset Management reported no remaining IDEAYA Biosciences position as of Q4 2024 after selling out during the quarter.
  • Allianz Asset Management sold 12,400 IDEAYA Biosciences shares in Q4 2024, an estimated $393K.
  • Allianz Asset Management first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 6 quarters.
  • Allianz Asset Management's IDEAYA Biosciences position peaked at $704K in Q4 2023.
  • 206 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2024.

Based on Allianz Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.